Retour
Prix CARsgen Therapeutics Holdings Limited (02171.HK)
Graphique du cours de l'action 02171.HK
CARSGEN-B (02171.HK)
CARsgen Therapeutics Holdings Limited
HK$15.07
1.14%
$0.16
Marché fermé: Feb 16, 12:00:00 HKT
Statistiques clés
Clôture préc.
$14.4
Prix d'ouverture
$14.9
Plage de la journée
$14.44 - $15.52
Plage de 52 semaines
$9.44 - $25.6
Volume
1.0M
Volume moyen
1.6M
BPA (TTM)
-1.07
Rendement en dividend
--
Capitalisation boursière
$8.2B
Qu’est-ce que CARSGEN-B ?
CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The company is headquartered in Shanghai, Shanghai and currently employs 371 full-time employees. The company went IPO on 2021-06-18. The Company’s main business is engaged in developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The firm conducts its business in the domestic and overseas markets.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.